Authored By: Sarah
11 Jul 2024

 Hydrocolloid Dressing Market to grow by USD 312.08 million between 2024-2028

According to a research report “ Hydrocolloid Dressing Market” by Application (Chronic wound, Acute wound) End-user (Hospitals, Clinics, Others) Geography (North America, Europe, Asia, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 312.08 million at a CAGR of  4.63% during the forecast period. In the healthcare industry, the rising prevalence of chronic and acute wounds, including diabetic foot ulcers, venous ulcers, pressure ulcers, burns, and traumatic ulcers, is driving demand for advanced wound care solutions. Hydrocolloid dressings, which provide a moist healing environment, are particularly effective for these types of wounds. The global diabetes mellitus patient population is projected to expand, increasing the number of individuals susceptible to diabetic foot ulcers. This trend underscores the growing business opportunity for hydrocolloid dressing manufacturers..

Browse market data tables, figures, and in-depth TOC on “Hydrocolloid Dressing Market” by Application (Chronic wound, Acute wound) End-user (Hospitals, Clinics, Others) Geography (North America, Europe, Asia, Rest of World (ROW)) Global Forecast to 2028.

 View detailed Table of Content- Click here

By Application, the Chronic wound segment is projected to dominate the market size in 2024.

In the global hydrocolloid dressing market, hospitals represent a significant market share due to the rising incidence of acute and chronic wounds, the increasing number of surgical procedures, and the growing awareness of advanced wound care solutions. The expansion of the hospital sector in developing countries, such as India, and the prevalence of chronic wounds are key growth drivers. For instance, Mission Regional Medical Center reports that approximately 6.7 million individuals are living with chronic wounds. Hospitals are also prioritizing cost reduction by shortening hospital stays and minimizing infection risks.

By End-user, Hospitals  segment is expected to hold the largest market size for the year 2024.

In the chronic wound market, hydrocolloid dressings hold a significant market share, projected to persist throughout the forecast period. The global prevalence of chronic wounds, including ulcers, traumatic wounds, and surgical wounds, impacts approximately 6.7 million individuals, with an anticipated growth of over 2% in the upcoming decade. Moreover, an estimated 150 million annual incidents of surgical incisions and traumatic wounds due to accidents further bolster market demand. The increasing number of road traffic accidents also contributes to this trend.

North America is forecasted to hold the largest market size by region in 2024.

The hydrocolloid dressing market in North America is experiencing significant growth, driven by the rising prevalence of acute and chronic wounds, the adoption of technologically superior dressings, and the presence of prominent market players. The US and Canada are the primary revenue generators, with the US leading due to the dominance of major key vendors. Enhanced awareness of advanced wound care solutions, such as hydrocolloid dressings, and advancements in moist wound dressing technologies are further fueling market expansion in this region.

The Hydrocolloid Dressing Market t growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • 3M Co.
  • AMERX Health Care Corp.
  • B.Braun SE
  • Cardinal Health Inc.
  • ConvaTec Group Plc
  • Covalon Technologies Ltd.
  • DermaRite Industries LLC
  • Essity AB
  • Hollister Inc.
  • Integra Lifesciences Corp.
  • Johnson and Johnson
  • Lohmann and Rauscher GmbH and Co. KG
  • McKesson Corp.
  • Medline Industries LP
  • Medtronic Plc
  • Molnlycke Health Care AB
  • Paul Hartmann AG
  • Roosin Medical Co. Ltd 
  • Smith and Nephew plc
  • Coloplast AS
.

For insights on company offerings- Request a sample report!

Research Analysis Overview

The Hydrocolloid Dressing Market encompasses innovative solutions for managing various types of wounds, including those associated with the American Diabetes Association, such as Diabetic foot ulcers and Venous leg ulcers. These dressings are widely used in healthcare settings, including Intensive Care Units (ICUs), and during surgical procedures to promote wound healing. Hydrocolloid dressings are available on platforms like ScienceDirect and ResearchGate, and are manufactured by companies like Avery Dennison Medical. They are effective in managing Acute wounds as well as Chronic wounds, and are particularly useful in the treatment of Pressure injuries and Trauma-related wounds, including Road traffic crashes, Miscellaneous burns, Electrical burns, Chemical burns, and Thermal burns. Hydrocolloid dressings are available in different forms, such as Nonwovens and Polyurethane films, and are essential in advanced wound care. The Brake Organization's ebmedicine provides comprehensive information on Severe burn injuries and the use of Hydrocolloid dressings in their treatment. The National Center for Biotechnology Information (NCBI) also hosts numerous studies on the efficacy of Hydrocolloid dressings in Wounds International.

Market Research Overview

The Hydrocolloid Dressing Market encompasses the production, sales, and distribution of hydrocolloid dressings, which are essential components in the treatment of various wounds, including acute and chronic ones. These dressings are particularly useful in managing pressure injuries, venous leg ulcers, diabetic foot ulcers, and trauma-related wounds. Hydrocolloid dressings are available from numerous healthcare suppliers and are often used in home healthcare settings, hospitals, and ICUs. They are also utilized in advanced wound care, such as autolytic debridement and surgical procedures, to promote skin healing and protect against infection. The market for hydrocolloid dressings is driven by the increasing geriatric population, the rising prevalence of chronic wounds, and the growing demand for effective wound care solutions. Key players in this market include providers of skin health solutions, medical tape, ostomy care products, surgical wound care, and pressure ulcer management. Notable companies include Avery Dennison Medical, ScienceDirect, and NCBI, among others. The hydrocolloid dressing market is expected to grow significantly due to the increasing focus on skin barrier protection and the development of advanced wound dressing materials, such as transparent dressings, hydrogel dressings, absorbent dressings, and adhesive dressings.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!
Technavio